Literature DB >> 33647033

Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.

Kathryn E Lafond1,2, Rachael M Porter1, Melissa J Whaley3, Zhou Suizan4, Zhang Ran4, Mohammad Abdul Aleem5, Binay Thapa6, Borann Sar7, Viviana Sotomayor Proschle8, Zhibin Peng9, Luzhao Feng10, Daouda Coulibaly11, Edith Nkwembe12, Alfredo Olmedo13, William Ampofo14, Siddhartha Saha15, Mandeep Chadha16, Amalya Mangiri17, Vivi Setiawaty18, Sami Sheikh Ali19, Sandra S Chaves20, Dinagul Otorbaeva21, Onechanh Keosavanh22, Majd Saleh23, Antonia Ho24,25, Burmaa Alexander26, Hicham Oumzil27,28, Kedar Prasad Baral29, Q Sue Huang30, Adedeji A Adebayo31, Idris Al-Abaidani32, Marta von Horoch33, Cheryl Cohen34, Stefano Tempia1,35,36, Vida Mmbaga37, Malinee Chittaganpitch38, Mariana Casal39, Duc Anh Dang40, Paula Couto41, Harish Nair42, Joseph S Bresee1, Sonja J Olsen1, Eduardo Azziz-Baumgartner1, J Pekka Nuorti2,43, Marc-Alain Widdowson44,45.   

Abstract

BACKGROUND: Influenza illness burden is substantial, particularly among young children, older adults, and those with underlying conditions. Initiatives are underway to develop better global estimates for influenza-associated hospitalizations and deaths. Knowledge gaps remain regarding the role of influenza viruses in severe respiratory disease and hospitalizations among adults, particularly in lower-income settings. METHODS AND
FINDINGS: We aggregated published data from a systematic review and unpublished data from surveillance platforms to generate global meta-analytic estimates for the proportion of acute respiratory hospitalizations associated with influenza viruses among adults. We searched 9 online databases (Medline, Embase, CINAHL, Cochrane Library, Scopus, Global Health, LILACS, WHOLIS, and CNKI; 1 January 1996-31 December 2016) to identify observational studies of influenza-associated hospitalizations in adults, and assessed eligible papers for bias using a simplified Newcastle-Ottawa scale for observational data. We applied meta-analytic proportions to global estimates of lower respiratory infections (LRIs) and hospitalizations from the Global Burden of Disease study in adults ≥20 years and by age groups (20-64 years and ≥65 years) to obtain the number of influenza-associated LRI episodes and hospitalizations for 2016. Data from 63 sources showed that influenza was associated with 14.1% (95% CI 12.1%-16.5%) of acute respiratory hospitalizations among all adults, with no significant differences by age group. The 63 data sources represent published observational studies (n = 28) and unpublished surveillance data (n = 35), from all World Health Organization regions (Africa, n = 8; Americas, n = 11; Eastern Mediterranean, n = 7; Europe, n = 8; Southeast Asia, n = 11; Western Pacific, n = 18). Data quality for published data sources was predominantly moderate or high (75%, n = 56/75). We estimate 32,126,000 (95% CI 20,484,000-46,129,000) influenza-associated LRI episodes and 5,678,000 (95% CI 3,205,000-9,432,000) LRI hospitalizations occur each year among adults. While adults <65 years contribute most influenza-associated LRI hospitalizations and episodes (3,464,000 [95% CI 1,885,000-5,978,000] LRI hospitalizations and 31,087,000 [95% CI 19,987,000-44,444,000] LRI episodes), hospitalization rates were highest in those ≥65 years (437/100,000 person-years [95% CI 265-612/100,000 person-years]). For this analysis, published articles were limited in their inclusion of stratified testing data by year and age group. Lack of information regarding influenza vaccination of the study population was also a limitation across both types of data sources.
CONCLUSIONS: In this meta-analysis, we estimated that influenza viruses are associated with over 5 million hospitalizations worldwide per year. Inclusion of both published and unpublished findings allowed for increased power to generate stratified estimates, and improved representation from lower-income countries. Together, the available data demonstrate the importance of influenza viruses as a cause of severe disease and hospitalizations in younger and older adults worldwide.

Entities:  

Mesh:

Year:  2021        PMID: 33647033      PMCID: PMC7959367          DOI: 10.1371/journal.pmed.1003550

Source DB:  PubMed          Journal:  PLoS Med        ISSN: 1549-1277            Impact factor:   11.069


  16 in total

1.  Meeting of the Strategic Advisory Group of Experts on immunization, April 2012--conclusions and recommendations.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2012-05-25

Review 2.  Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.

Authors:  Alexander Domnich; Lucia Arata; Daniela Amicizia; Joan Puig-Barberà; Roberto Gasparini; Donatella Panatto
Journal:  Vaccine       Date:  2016-12-23       Impact factor: 3.641

3.  Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial.

Authors:  Stefan Gravenstein; H Edward Davidson; Monica Taljaard; Jessica Ogarek; Pedro Gozalo; Lisa Han; Vincent Mor
Journal:  Lancet Respir Med       Date:  2017-07-20       Impact factor: 30.700

Review 4.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Authors:  Michael T Osterholm; Nicholas S Kelley; Alfred Sommer; Edward A Belongia
Journal:  Lancet Infect Dis       Date:  2011-10-25       Impact factor: 25.071

5.  The burden of influenza in young children, 2004-2009.

Authors:  Katherine A Poehling; Kathryn M Edwards; Marie R Griffin; Peter G Szilagyi; Mary A Staat; Marika K Iwane; Beverly M Snively; Cynthia K Suerken; Caroline B Hall; Geoffrey A Weinberg; Sandra S Chaves; Yuwei Zhu; Monica M McNeal; Carolyn B Bridges
Journal:  Pediatrics       Date:  2013-01-06       Impact factor: 7.124

6.  Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype.

Authors:  Sandra S Chaves; Deborah Aragon; Nancy Bennett; Tara Cooper; Tiffany D'Mello; Monica Farley; Brian Fowler; Emily Hancock; Pam Daily Kirley; Ruth Lynfield; Patricia Ryan; William Schaffner; Ruta Sharangpani; Leslie Tengelsen; Ann Thomas; Diana Thurston; Jean Williams; Kimberly Yousey-Hindes; Shelley Zansky; Lyn Finelli
Journal:  J Infect Dis       Date:  2013-07-17       Impact factor: 5.226

7.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

8.  Progress and Remaining Gaps in Estimating the Global Disease Burden of Influenza.

Authors:  Joseph Bresee; Julia Fitzner; Harry Campbell; Cheryl Cohen; Vanessa Cozza; Jorge Jara; Anand Krishnan; Vernon Lee
Journal:  Emerg Infect Dis       Date:  2018-07       Impact factor: 6.883

9.  Incidence of hospitalisation for severe complications of influenza virus infection in Japanese patients between 2012 and 2016: a cross-sectional study using routinely collected administrative data.

Authors:  Hiroshi Yokomichi; Mie Mochizuki; Joseph Jonathan Lee; Reiji Kojima; Tetsuji Yokoyama; Zentaro Yamagata
Journal:  BMJ Open       Date:  2019-01-17       Impact factor: 2.692

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more
  22 in total

1.  Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009-2017.

Authors:  Allen L Nazareno; David J Muscatello; Robin M Turner; James G Wood; Hannah C Moore; Anthony T Newall
Journal:  Influenza Other Respir Viruses       Date:  2022-06-30       Impact factor: 5.606

Review 2.  Human Innate Lymphoid Cells in Influenza Infection and Vaccination.

Authors:  Amrita Kumar; Rashmi Kumari; Timothy Liu; Weiping Cao; Bruce A Davidson; Paul R Knight; Suryaprakash Sambhara
Journal:  Crit Rev Immunol       Date:  2021       Impact factor: 1.735

Review 3.  Influenza Virus Infections in Polarized Cells.

Authors:  Beatriz Praena; Xiu-Feng Wan
Journal:  Viruses       Date:  2022-06-15       Impact factor: 5.818

4.  Interferon-γ promotes monocyte-mediated lung injury during influenza infection.

Authors:  Taylor Schmit; Kai Guo; Jitendra Kumar Tripathi; Zhihan Wang; Brett McGregor; Mitch Klomp; Ganesh Ambigapathy; Ramkumar Mathur; Junguk Hur; Michael Pichichero; Jay Kolls; M Nadeem Khan
Journal:  Cell Rep       Date:  2022-03-01       Impact factor: 9.995

Review 5.  From high-throughput to therapeutic: host-directed interventions against influenza viruses.

Authors:  Joseph D Trimarco; Nicholas S Heaton
Journal:  Curr Opin Virol       Date:  2022-01-11       Impact factor: 7.121

Review 6.  Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance.

Authors:  Arun B Arunachalam; Penny Post; Deborah Rudin
Journal:  NPJ Vaccines       Date:  2021-12-02       Impact factor: 7.344

7.  Myeloid Protease-Activated Receptor-2 Contributes to Influenza A Virus Pathology in Mice.

Authors:  Randall C Gunther; Vanthana Bharathi; Stephen D Miles; Lauryn R Tumey; Clare M Schmedes; Kohei Tatsumi; Meagan D Bridges; David Martinez; Stephanie A Montgomery; Melinda A Beck; Eric Camerer; Nigel Mackman; Silvio Antoniak
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

8.  Regional-based within-year seasonal variations in influenza-related health outcomes across mainland China: a systematic review and spatio-temporal analysis.

Authors:  W John Edmunds; Marc Baguelin; Charlie Diamond; Hui Gong; Fiona Yueqian Sun; Yang Liu; Billy J Quilty; Mark Jit; Juan Yang; Hongjie Yu
Journal:  BMC Med       Date:  2022-02-10       Impact factor: 8.775

Review 9.  Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection.

Authors:  Catalina A Andrade; Alexis M Kalergis; Karen Bohmwald
Journal:  Pathogens       Date:  2021-12-31

Review 10.  Relative Effectiveness of Cell-Cultured versus Egg-Based Seasonal Influenza Vaccines in Preventing Influenza-Related Outcomes in Subjects 18 Years Old or Older: A Systematic Review and Meta-Analysis.

Authors:  Joan Puig-Barberà; Sonia Tamames-Gómez; Pedro Plans-Rubio; José María Eiros-Bouza
Journal:  Int J Environ Res Public Health       Date:  2022-01-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.